1. A Career in Military Psychiatry. Issue 2 (1st June 2008) Authors: Pook, A; Tarn, M; Harrison, J; McAllister, P; Greenberg, N Journal: Journal of the Royal Army Medical Corps Issue: Volume 154:Issue 2(2008) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P.015 Monthly migraine days, acute medication use-days, and migraine-specific quality of life in responders to atogepant: a post hoc analysis. (June 2022) Authors: Dodick, DW; Lipton, RB; Nahas, SJ; Pozo-Rosich, P; McAllister, P; Mechtler, LL; Leroux, E; Ma, J; Dabruzzo, B; Dufek, M; Severt, L; Finnegan, M; Trugman, J Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.016 Reduction in migraine-associated burden over 24 weeks of treatment with eptinezumab in patients with chronic migraine. (June 2022) Authors: McAllister, P; Kudrow, D; Cady, R; Hirman, J; Ettrup, A; Minhas, S Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P.020 Long-term safety and tolerability of atogepant 60mg once daily for preventive treatment of migraine: a phase 3, 40-week, multicenter extension to the advance trial. (June 2022) Authors: Klein, B; Miceli, R; Severt, L; McAllister, P; Mechtler, L; McVige, J; Diamond, M; Marmura, MJ; Leroux, E; Guo, H; Finnegan, M; Trugman, J Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P.027 Efficacy and Safety of Eptinezumab Initiated During a Migraine Attack: Results from the RELIEF Study. (November 2021) Authors: Winner, PK; McAllister, P; Chakhava, G; Ailani, J; Mehta, L; Ettrup, A; Krog Josiassen, M; Lindsten, A; Bougie, JK; Cady, R Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P.029 Oral Daily Atogepant for the Preventive Treatment of Migraine Increases Responder Rates for Reduction in Mean Monthly Migraine Days. (November 2021) Authors: Lipton, RB; Pozo-Rosich, P; Blumenfeld, AM; Dodick, DW; McAllister, P; Li, Y; Lu, K; Dabruzzo, B; Davidovic, G; Miceli, R; Severt, L; Finnegan, M; Trugman, JM Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗